tiprankstipranks
Trending News
More News >
Medtronic (MDT)
NYSE:MDT
US Market
Advertisement

Medtronic (MDT) Stock Forecast & Price Target

Compare
6,238 Followers
See the Price Targets and Ratings of:

MDT Analyst Ratings

Moderate Buy
27Ratings
Moderate Buy
13 Buy
13 Hold
1 Sell
Based on 27 analysts giving stock ratings to
Medtronic
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MDT Stock 12 Month Forecast

Average Price Target

$99.48
▲(8.07% Upside)
Based on 27 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $99.48 with a high forecast of $115.00 and a low forecast of $78.00. The average price target represents a 8.07% change from the last price of $92.05.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"76":"$76","86":"$86","96":"$96","106":"$106","116":"$116"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":115,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$115.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":99.48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$99.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":78,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$78.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[76,86,96,106,116],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.34,91.31384615384616,93.28769230769231,95.26153846153846,97.23538461538462,99.20923076923077,101.18307692307692,103.15692307692308,105.13076923076923,107.10461538461539,109.07846153846154,111.05230769230769,113.02615384615385,{"y":115,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.34,90.12,90.9,91.68,92.46000000000001,93.24000000000001,94.02000000000001,94.8,95.58,96.36,97.14,97.92,98.7,{"y":99.48,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.34,88.46769230769232,87.59538461538462,86.72307692307693,85.85076923076923,84.97846153846154,84.10615384615384,83.23384615384616,82.36153846153846,81.48923076923077,80.61692307692307,79.74461538461539,78.87230769230769,{"y":78,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":77.9,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.74,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.8,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.86,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.42,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.6,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.54,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.87,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.05,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.75,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$115.00Average Price Target$99.48Lowest Price Target$78.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
$101
Buy
9.72%
Upside
Reiterated
08/27/25
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Medtronic (NYSE: MDT)
Argus Research Analyst forecast on MDT
Argus Research
Argus Research
$115
Buy
24.93%
Upside
Reiterated
08/25/25
Medtronic price target raised to $115 from $105 at ArgusMedtronic price target raised to $115 from $105 at Argus
Wolfe Research Analyst forecast on MDT
Wolfe Research
Wolfe Research
Hold
Reiterated
08/25/25
Wolfe Research Sticks to Their Hold Rating for Medtronic (MDT)Wolfe Research analyst Mike Polark reiterated a Peerperform rating on Medtronic, Inc. (NYSE: MDT).
TD Cowen
$106
Buy
15.15%
Upside
Reiterated
08/25/25
TD Cowen Keeps Their Buy Rating on Medtronic (MDT)
Truist Financial Analyst forecast on MDT
Truist Financial
Truist Financial
$92$96
Hold
4.29%
Upside
Reiterated
08/21/25
Truist Financial Sticks to Their Hold Rating for Medtronic (MDT)
Wells Fargo Analyst forecast on MDT
Wells Fargo
Wells Fargo
$98$100
Buy
8.64%
Upside
Reiterated
08/20/25
Medtronic price target raised to $100 from $98 at Wells FargoMedtronic price target raised to $100 from $98 at Wells Fargo
Barclays Analyst forecast on MDT
Barclays
Barclays
$109
Buy
18.41%
Upside
Reiterated
08/20/25
Medtronic (MDT) Gets a Buy from Barclays
J.P. Morgan Analyst forecast on MDT
J.P. Morgan
J.P. Morgan
$87$90
Hold
-2.23%
Downside
Reiterated
08/20/25
J.P. Morgan Keeps Their Hold Rating on Medtronic (MDT)JPMorgan analyst Robbie Marcus raised the price target on Medtronic, Inc. (NYSE: MDT) to $90.00 (from $87.00) while maintaining a Neutral rating.
Bernstein Analyst forecast on MDT
Bernstein
Bernstein
$97$98
Buy
6.46%
Upside
Reiterated
08/20/25
Medtronic price target raised to $98 from $97 at BernsteinMedtronic price target raised to $98 from $97 at Bernstein
Robert W. Baird Analyst forecast on MDT
Robert W. Baird
Robert W. Baird
$94$96
Hold
4.29%
Upside
Reiterated
08/20/25
Medtronic price target raised to $96 from $94 at BairdMedtronic price target raised to $96 from $94 at Baird
Leerink Partners Analyst forecast on MDT
Leerink Partners
Leerink Partners
$110$111
Buy
20.59%
Upside
Reiterated
08/20/25
Medtronic (MDT) Gets a Buy from Leerink Partners
UBS
$94$95
Hold
3.20%
Upside
Reiterated
08/20/25
Medtronic price target raised to $95 from $94 at UBSMedtronic price target raised to $95 from $94 at UBS
Evercore ISI Analyst forecast on MDT
Evercore ISI
Evercore ISI
$106$107
Buy
16.24%
Upside
Reiterated
08/20/25
Evercore ISI Sticks to Its Buy Rating for Medtronic (MDT)
RBC Capital
$101$103
Buy
11.90%
Upside
Reiterated
08/20/25
RBC Capital Sticks to Their Buy Rating for Medtronic (MDT)RBC Capital analyst Shagun Singh raised the price target on Medtronic, Inc. (NYSE: MDT) to $103.00 (from $101.00) while maintaining a Outperform rating.
Morgan Stanley Analyst forecast on MDT
Morgan Stanley
Morgan Stanley
$107
Buy
16.24%
Upside
Reiterated
08/20/25
Morgan Stanley Reaffirms Their Buy Rating on Medtronic (MDT)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
$101
Buy
9.72%
Upside
Reiterated
08/27/25
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Medtronic (NYSE: MDT)
Argus Research Analyst forecast on MDT
Argus Research
Argus Research
$115
Buy
24.93%
Upside
Reiterated
08/25/25
Medtronic price target raised to $115 from $105 at ArgusMedtronic price target raised to $115 from $105 at Argus
Wolfe Research Analyst forecast on MDT
Wolfe Research
Wolfe Research
Hold
Reiterated
08/25/25
Wolfe Research Sticks to Their Hold Rating for Medtronic (MDT)Wolfe Research analyst Mike Polark reiterated a Peerperform rating on Medtronic, Inc. (NYSE: MDT).
TD Cowen
$106
Buy
15.15%
Upside
Reiterated
08/25/25
TD Cowen Keeps Their Buy Rating on Medtronic (MDT)
Truist Financial Analyst forecast on MDT
Truist Financial
Truist Financial
$92$96
Hold
4.29%
Upside
Reiterated
08/21/25
Truist Financial Sticks to Their Hold Rating for Medtronic (MDT)
Wells Fargo Analyst forecast on MDT
Wells Fargo
Wells Fargo
$98$100
Buy
8.64%
Upside
Reiterated
08/20/25
Medtronic price target raised to $100 from $98 at Wells FargoMedtronic price target raised to $100 from $98 at Wells Fargo
Barclays Analyst forecast on MDT
Barclays
Barclays
$109
Buy
18.41%
Upside
Reiterated
08/20/25
Medtronic (MDT) Gets a Buy from Barclays
J.P. Morgan Analyst forecast on MDT
J.P. Morgan
J.P. Morgan
$87$90
Hold
-2.23%
Downside
Reiterated
08/20/25
J.P. Morgan Keeps Their Hold Rating on Medtronic (MDT)JPMorgan analyst Robbie Marcus raised the price target on Medtronic, Inc. (NYSE: MDT) to $90.00 (from $87.00) while maintaining a Neutral rating.
Bernstein Analyst forecast on MDT
Bernstein
Bernstein
$97$98
Buy
6.46%
Upside
Reiterated
08/20/25
Medtronic price target raised to $98 from $97 at BernsteinMedtronic price target raised to $98 from $97 at Bernstein
Robert W. Baird Analyst forecast on MDT
Robert W. Baird
Robert W. Baird
$94$96
Hold
4.29%
Upside
Reiterated
08/20/25
Medtronic price target raised to $96 from $94 at BairdMedtronic price target raised to $96 from $94 at Baird
Leerink Partners Analyst forecast on MDT
Leerink Partners
Leerink Partners
$110$111
Buy
20.59%
Upside
Reiterated
08/20/25
Medtronic (MDT) Gets a Buy from Leerink Partners
UBS
$94$95
Hold
3.20%
Upside
Reiterated
08/20/25
Medtronic price target raised to $95 from $94 at UBSMedtronic price target raised to $95 from $94 at UBS
Evercore ISI Analyst forecast on MDT
Evercore ISI
Evercore ISI
$106$107
Buy
16.24%
Upside
Reiterated
08/20/25
Evercore ISI Sticks to Its Buy Rating for Medtronic (MDT)
RBC Capital
$101$103
Buy
11.90%
Upside
Reiterated
08/20/25
RBC Capital Sticks to Their Buy Rating for Medtronic (MDT)RBC Capital analyst Shagun Singh raised the price target on Medtronic, Inc. (NYSE: MDT) to $103.00 (from $101.00) while maintaining a Outperform rating.
Morgan Stanley Analyst forecast on MDT
Morgan Stanley
Morgan Stanley
$107
Buy
16.24%
Upside
Reiterated
08/20/25
Morgan Stanley Reaffirms Their Buy Rating on Medtronic (MDT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

1 Month
xxx
Success Rate
13/22 ratings generated profit
59%
Average Return
+1.66%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +1.66% per trade.
3 Months
xxx
Success Rate
17/22 ratings generated profit
77%
Average Return
+4.00%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +4.00% per trade.
1 Year
Larry BiegelsenWells Fargo
Success Rate
24/30 ratings generated profit
80%
Average Return
+7.13%
reiterated a buy rating 9 days ago
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +7.13% per trade.
2 Years
xxx
Success Rate
23/25 ratings generated profit
92%
Average Return
+10.00%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 92.00% of your transactions generating a profit, with an average return of +10.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDT Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
23
33
43
53
50
Hold
18
18
18
22
23
Sell
1
0
0
1
2
Strong Sell
0
0
0
0
0
total
42
51
61
76
75
In the current month, MDT has received 50 Buy Ratings, 23 Hold Ratings, and 2 Sell Ratings. MDT average Analyst price target in the past 3 months is 99.48.
Each month's total comprises the sum of three months' worth of ratings.

MDT Financial Forecast

MDT Earnings Forecast

Next quarter’s earnings estimate for MDT is $1.31 with a range of $1.31 to $1.33. The previous quarter’s EPS was $1.26. MDT beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.
Next quarter’s earnings estimate for MDT is $1.31 with a range of $1.31 to $1.33. The previous quarter’s EPS was $1.26. MDT beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.

MDT Sales Forecast

Next quarter’s sales forecast for MDT is $8.86B with a range of $8.75B to $8.91B. The previous quarter’s sales results were $8.58B. MDT beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.
Next quarter’s sales forecast for MDT is $8.86B with a range of $8.75B to $8.91B. The previous quarter’s sales results were $8.58B. MDT beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.

MDT Stock Forecast FAQ

What is MDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Medtronic’s 12-month average price target is 99.48.
    What is MDT’s upside potential, based on the analysts’ average price target?
    Medtronic has 8.07% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MDT a Buy, Sell or Hold?
          Medtronic has a consensus rating of Moderate Buy which is based on 13 buy ratings, 13 hold ratings and 1 sell ratings.
            What is Medtronic’s price target?
            The average price target for Medtronic is 99.48. This is based on 27 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $115.00 ,the lowest forecast is $78.00. The average price target represents 8.07% Increase from the current price of $92.05.
              What do analysts say about Medtronic?
              Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 27 Wall Streets Analysts.
                How can I buy shares of MDT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis